← Eichor
Study identifier: NCT07473375 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Indicators Affecting PVT Recanalization

Condition: Portal Vein Thrombosis · Cirrhosis · Portal Hypertension Related to Cirrhosis  ·  Sponsor: Shanghai Zhongshan Hospital

PhaseN/A
Planned participants1500
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This is a retrospective-prospective study conducted at Zhongshan Hospital, Fudan University, to explore portal vein thrombosis (PVT) in patients with cirrhosis and gastroesophageal varices (GEV). It aimed to provide insights into the diagnosis, follow-up, and factors influencing PVT recanalization, to help patients, families, and healthcare providers understand the disease and related clinical management.

This description comes directly from the study's public registry record.

Talk to the study team

Siyu Jiang, Dr.  ·  +86-15121068078  ·  ksjsy1996926@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Study siteShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07473375